Anti-G-CSF antibody [EPR3203(N)(B)]
- RabMAb
- Recombinant
- What is this?
4
(1 Review)
|
(16 Publications)
Rabbit Recombinant Monoclonal G-CSF antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 16 publications.
View Alternative Names
C17orf33, GCSF, CSF3, Granulocyte colony-stimulating factor, G-CSF, Pluripoietin
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
Intracellular Flow Cytometry analysis of K562 (human chronic myelogenous leukemia) cells labeling G-CSF with purified ab181053 at 1/200 dilution (10ug/mL) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
Immunocytochemistry/ Immunofluorescence analysis of BxPC-3 (Human pancreas adenocarcinoma epithelial cell) cells labeling G-CSF with Purified ab181053 at 1 : 500 dilution (4.0μg/ml). Cells were fixed in 100% Methanol. ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear was used as a counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
Immunofluorescent analysis of HT-1376 cells (paraformaldehyde-fixed, 4%) labeling G-CSF with unpurified ab181053 at 1/100 dilution followed by Goat anti rabbit IgG (Alexa Fluor® 488) secondary at 1/200 dilution and counter-stained with DAPI (blue).
- IP
Supplier Data
Immunoprecipitation - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
Western blot analysis of immunoprecipitation pellet from K562 cell lysate (lane 1) or a Negative control (lane 2) immunoprecipitated using unpurified ab181053 at 1/20 dilution.
Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-G-CSF antibody [EPR3203(N)(B)] (ab181053)
Predicted band size: 22 kDa
false
- IP
Lab
Immunoprecipitation - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
ab181053 (purified) at 1 : 100 dilution (2ug) immunoprecipitating G-CSF in K562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate.
Lane 1 (input) : K562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate 10ug
Lane 2 (+) : ab181053 & K562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab181053 in K562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate.
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST."
All lanes:
Immunoprecipitation - Anti-G-CSF antibody [EPR3203(N)(B)] (ab181053)
Predicted band size: 22 kDa
false
- WB
Lab
Western blot - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-G-CSF antibody [EPR3203(N)(B)] (ab181053) at 1/2000 dilution
Lane 1:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysates at 20 µg
Lane 2:
HT-1376 (Human urinary bladder carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 3:
Mouse brain lysates at 20 µg
Lane 4:
Rat brain lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 22 kDa
Observed band size: 25 kDa
false
- WB
Supplier Data
Western blot - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
All lanes:
Western blot - Anti-G-CSF antibody [EPR3203(N)(B)] (ab181053) at 1/2000 dilution
Lane 1:
K562 cell lysate at 20 µg
Lane 2:
KM3 cell lysate at 20 µg
Lane 3:
NCI-H460 cell lysate at 20 µg
Lane 4:
HT-1376 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L) HRP at 1/1000 dilution
Predicted band size: 22 kDa
false
- WB
Lab
Western blot - Anti-G-CSF antibody [EPR3203(N)(B)] (AB181053)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 4 s
All lanes:
Western blot - Anti-G-CSF antibody [EPR3203(N)(B)] (ab181053) at 1/1000 dilution
Lane 1:
A549 (Human lung carcinoma epithelial cell) cell lysate at 10 µg
Lane 2:
K-562 (Human chronic myelogenous leukemia lymphoblast) cell lysate at 10 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) cell lysate at 10 µg
Lane 4:
HeLa (Human cervix adenocarcinoma epithelial cell) cell lysate at 10 µg
Lane 5:
MCF7 (Human breast adenocarcinoma epithelial cell) cell lysate at 10 µg
Lane 6:
MOLT-4 (Human lymphoblastic leukemia T lymphoblast) cell lysate at 10 µg
Lane 7:
PC-3 (Human prostate adenocarcinoma epithelial cell) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 22 kDa
Observed band size: 25 kDa
false
Related conjugates and formulations (9)
-
HRP Anti-G-CSF antibody [EPR3203(N)(B)]
-
Anti-G-CSF antibody [EPR3203(N)(B)] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-G-CSF antibody [EPR3203(N)(B)]
-
578 PE
PE Anti-G-CSF antibody [EPR3203(N)(B)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-G-CSF antibody [EPR3203(N)(B)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-G-CSF antibody [EPR3203(N)(B)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-G-CSF antibody [EPR3203(N)(B)]
-
660 APC
APC Anti-G-CSF antibody [EPR3203(N)(B)]
-
Anti-G-CSF antibody [EPR3203(N)(B)] - Low endotoxin, Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Translational oncology 53:102310 PubMed39929064
2025
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 65:17 PubMed39652067
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pharmacology and experimental therapeutics : PubMed38955493
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 80:184 PubMed37340199
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genes to cells : devoted to molecular & cellular mechanisms 28:573-584 PubMed37248626
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 29:1742-1750 PubMed35768562
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in microbiology 13:837776 PubMed35572651
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:4877275 PubMed35308175
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of investigative dermatology 142:692-704.e14 PubMed34517005
2021
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 21:299 PubMed34118920
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com